We use cookies for a better user experience. Read our Privacy Policy

I Agree

Industry Verticals »

All Categories

Insights »

About TMR »

Continuous Glucose Monitoring Market

Schedule a Call

Continuous Glucose Monitoring Market

Continuous Glucose Monitoring Market (Device/Brand: Guardian Real Time CGM System, Freestyle Navigator, Dexcom Seven Plus CGM System, Dexcom G4 Platinum, Mini Med Paradigm Revel/Veo Systems, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Continuous Glucose Monitoring Market Outlook 2028

  • The global market was valued at US$ 992.8 Mn in 2020
  • It is estimated to expand at a CAGR of 9.5% from 2021 to 2028
  • The global continuous glucose monitoring devices market is expected to surpass the value of US$ 2 Bn by the end of 2028

Continuous Glucose Monitoring Industry: Overview

  • An increase in the incidence and prevalence rate of diabetes type 1 and type 2 across the globe is anticipated to boost the growth of the global market during the forecast period
  • Continuous glucose monitoring systems are real-time glucose sensing and monitoring devices that measure and display the glucose levels of a patient at regular intervals. The usage of CGM is substantially increasing over traditional glucose monitoring systems, as these systems are user-friendly, provide access to real-time values and trends, and provide enhanced accuracy.
  • Additionally, it has been observed that continuous glucose monitoring significantly helps in diabetes management, especially in type I diabetics, and helps in reducing long-term complications associated with diabetes. A rise in awareness in developed and developing countries, technological advancements, and an increase in the number of diabetic patients are key factors expected to fuel the growth of the global market during the forecast period.

Request a sample to get extensive insights into the Continuous Glucose Monitoring Market

Continuous Glucose Monitoring (CGM) Market: Segmentation

  • The global continuous glucose monitoring market has been segmented based on device/brand and country/sub-region
  • In terms of device/brand, the global continuous glucose monitoring industry has been classified into Guardian Real Time CGM system, Dexcom Seven Plus, Dexcom G4 Platinum, FreeStyle Navigator, MiniMed Paradigm Revel/Veo System, and others
  • The Guardian Real Time CGM System segment accounted for a major market share in 2020, owing to the presence of large companies, such as Medtronic, providing CGM systems in the market for diabetes management. The systems are widely adopted by consumers, as these are considered efficient sensors for usage as fitness trackers for diabetes. The Dexcom G4 Platinum CGM System segment is expected to witness the fastest growth during the forecast period.

To understand how our report can bring a difference to your business strategy, Ask for a brochure

Continuous Glucose Monitoring Market: Country/Sub-region Segmentation

  • In terms of country/sub-region, the global continuous glucose monitoring market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the market in 2020, followed by Europe and Asia Pacific. The U.S. accounted for a significant market share in 2020 in the region owing to a large patient pool, increase in the geriatric population, rise in baby boomers, sedentary lifestyles, and undiagnosed diabetic patient population is expected to propel the continuous glucose monitoring devices market in North America. Approvals of innovative CGM systems by the FDA and the rise in innovative companies developing CGM systems are likely to augment the market in the region in the near future.
  • The market in Asia Pacific is likely to grow at a rapid pace from 2021 to 2028. The rapid rise in the diabetic population across the region has increased the demand for effective diabetes management systems. This can be attributed to the surge in the incidence rate of diabetes, an unhealthy lifestyle, technically advanced products, and a rise in the usage of CGM over traditional glucose monitoring systems.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Continuous Glucose Monitoring Market

Continuous Glucose Monitoring Devices Market: Major Players

  • Key players operating in the global continuous glucose monitoring business include
    • Abbott
    • Bayer AG
    • Dexcom, Inc.
    • Glysens Incorporated
    • Insulet Corporation
    • Medtronic
    • Nova Biomedical Corporation
    • Senseonics Incorporated
    • Livongo
    • BeatO
    • Jana Care
    • iXensor
    • DiaMonTech AG
  • These players focus on adopting various strategies to strengthen market presence, expand product offerings, and strengthen geographic presence. Launch of innovative product offerings, mergers & acquisitions, faster approval of CGM devices, and delivering & creating awareness about continuous glucose monitoring systems are projected to boost the growth of the global continuous glucose monitoring market during the forecast period. Entry into the domestic market in developing countries and offering product line at low cost is a key strategy adopted by the major players to expand in emerging markets.

Continuous Glucose Monitoring Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 992.8 Mn

Market Forecast Value in 2028

US$ 2,065.5 Mn

Growth Rate (CAGR)

9.5%

Forecast Period

2021–2028

Quantitative Units

US$ Mn for Value & ‘000 Units for Volume

Market Analysis

The report includes cross segment analysis at global as well as regional level. Qualitative analysis includes drivers, restraints, opportunities, key trends, etc. The report includes value of various continuous glucose monitoring devices across regional and global level.

Competition Landscape
  • Market share analysis by company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, key financials, etc.

Format

Electronic (PDF) + Excel

Market Segmentation
  • Device/Brand
    • Guardian Real Time CGM System
    • Dexcom Seven Plus
    • Dexcom G4 Platinum
    • FreeStyle Navigator
    • MiniMed Paradigm Revel/Veo System
    • Others

Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Companies Profiled
  • Abbott
  • Bayer AG
  • Dexcom, Inc.
  • Glysens Incorporated
  • Insulet Corporation
  • Medtronic
  • Nova Biomedical Corporation
  • Senseonics Incorporated
  • Livongo
  • BeatO
  • Jana Care
  • iXensor
  • DiaMonTech AG.

Customization Scope

Available upon request

Pricing

Available upon request

Continuous Glucose Monitoring Market – Segmentation

Device/Brand
  • Guardian Real Time CGM System
  • Freestyle Navigator
  • Dexcom Seven Plus CGM System
  • Dexcom G4 Platinum
  • Mini Med Paradigm Revel/Veo Systems
  • Others (iPro 2, Sentrino)
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of continuous glucose monitoring market?

The continuous glucose monitoring (CGM) market is expected to surpass the value of US$ 2 Bn by the end of 2028

What is the anticipated CAGR of the global market for continuous glucose monitoring in the forecast period?

The continuous glucose monitoring market is estimated to expand at a CAGR of 9.5% from 2021 to 2028

What are the key driving factors for the growth of the continuous glucose monitoring devices market?

The continuous glucose monitoring (CGM) market is driven by an increase in the incidence and prevalence rate of diabetes type 1 and type 2 across the globe.

Which region is expected to project the highest market share in the global continuous glucose monitoring business?

North America accounted for a major share of the global CGM market

Who are the key players in the global continuous glucose monitoring industry?

Key players operating in the global continuous glucose monitoring market includes Abbott, Bayer AG, Dexcom, Inc., Glysens Incorporated, Insulet Corporation, Medtronic, Nova Biomedical Corporation

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Continuous Glucose Monitoring Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Market Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Continuous Glucose Monitoring  Market Analysis and Forecast, 2017–2028

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Technological Advancements

        5.2. Prevalence & Incidence rate of Diabetes across globe

        5.3. Pricing Analysis of devices

        5.4. Overview of Point-of-care Testing

        5.5. COVID-19 pandemic impact on Global Continuous Glucose Monitoring Market

    6. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Device/Brand

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017–2028

            6.3.1. Guardian Real Time CGM System

            6.3.2. FreeStyle Navigator

            6.3.3. Dexcom Seven Plus CGM System

            6.3.4. Dexcom G4 Platinum

            6.3.5. MiniMed Paradigm Revel/Veo Systems

            6.3.6. Others

        6.4. Global  Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand,2021–2028

    7. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Country/Sub-region

        7.1. Key Findings

        7.2. Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Region

            7.2.1. North America

            7.2.2. Europe

            7.2.3. Asia Pacific

            7.2.4. Latin America

            7.2.5. Middle East & Africa

        7.3. Global Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/Region,2017–2028

    8. North America Continuous Glucose Monitoring Market Analysis and Forecast

        8.1. Introduction

            8.1.1. Key Findings

        8.2. North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017–2028

            8.2.1. Guardian Real Time CGM System

            8.2.2. FreeStyle Navigator

            8.2.3. Dexcom Seven Plus CGM System

            8.2.4. Dexcom G4 Platinum

            8.2.5. MiniMed Paradigm Revel/Veo Systems

            8.2.6. Others

        8.3. North America Continuous Glucose Monitoring Market Analysis, by Country, 2017–2028

            8.3.1. U.S.

            8.3.2. Canada

        8.4. North America Continuous Glucose Monitoring Market Attractiveness Analysis, 2021–2028

            8.4.1. By Device/Brand

            8.4.2. By Country/Sub-region

    9. Europe Continuous Glucose Monitoring  Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017–2028

            9.2.1. Guardian Real Time CGM System

            9.2.2. FreeStyle Navigator

            9.2.3. Dexcom Seven Plus CGM System

            9.2.4. Dexcom G4 Platinum

            9.2.5. MiniMed Paradigm Revel/Veo Systems

            9.2.6. Others

        9.3. Europe Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017–2028

            9.3.1. Germany

            9.3.2. U.K.

            9.3.3. France

            9.3.4. Italy

            9.3.5. Spain

            9.3.6. Rest of Europe

        9.4. Europe Continuous Glucose Monitoring Market Attractiveness Analysis, 2021–2028

            9.4.1. By Device/Brand

            9.4.2. By Country/Sub-region

    10. Asia Pacific Continuous Glucose Monitoring Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017–2028

            10.2.1. Guardian Real Time CGM System

            10.2.2. FreeStyle Navigator

            10.2.3. Dexcom Seven Plus CGM System

            10.2.4. Dexcom G4 Platinum

            10.2.5. MiniMed Paradigm Revel/Veo Systems

        10.3. Asia Pacific Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017–2028

            10.3.1. China

            10.3.2. Japan

            10.3.3. India

            10.3.4. Australia & New Zealand

            10.3.5. Rest of Asia Pacific

        10.4. Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, 2021–2028

            10.4.1. By Device/Brand

            10.4.2. By Country/Sub-region

    11. Latin America Continuous Glucose Monitoring Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017–2028

            11.2.1. Guardian Real Time CGM System

            11.2.2. FreeStyle Navigator

            11.2.3. Dexcom Seven Plus CGM System

            11.2.4. Dexcom G4 Platinum

            11.2.5. MiniMed Paradigm Revel/Veo Systems

        11.3. Latin America Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017–2028

            11.3.1. Brazil

            11.3.2. Mexico

            11.3.3. Rest of Latin America

        11.4. Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, 2021–2028

            11.4.1. By Device/Brand

            11.4.2. By Country/Sub-region

    12. Middle East & Africa Continuous Glucose Monitoring Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017–2028

            12.2.1. Guardian Real Time CGM System

            12.2.2. FreeStyle Navigator

            12.2.3. Dexcom Seven Plus CGM System

            12.2.4. Dexcom G4 Platinum

            12.2.5. MiniMed Paradigm Revel/Veo Systems

        12.3. Middle East & Africa Continuous Glucose Monitoring Market Analysis, by Country/Sub-region, 2017–2028

            12.3.1. GCC Countries

            12.3.2. South Africa

            12.3.3. Rest of Middle East & Africa

        12.4. Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, 2021–2028

            12.4.1. By Device/Brand

            12.4.2. By Country/Sub-region

    13. Competitive Landscape

        13.1. Company Profiles (2020)

            13.1.1. Abbott

                13.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.1.1.2. Product Portfolio

                13.1.1.3. Financial Overview

                13.1.1.4. Strategic Overview

                13.1.1.5. SWOT Analysis

            13.1.2. Bayer AG

                13.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.1.2.2. Product Portfolio

                13.1.2.3. Financial Overview

                13.1.2.4. Strategic Overview

                13.1.2.5. SWOT Analysis

            13.1.3. Dexcom, Inc.

                13.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.1.3.2. Product Portfolio

                13.1.3.3. Financial Overview

                13.1.3.4. Strategic Overview

                13.1.3.5. SWOT Analysis

            13.1.4. Glysens Incorporated

                13.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.1.4.2. Product Portfolio

                13.1.4.3. Strategic Overview

                13.1.4.4. SWOT Analysis

            13.1.5. Insulet Corporation

                13.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.1.5.2. Product Portfolio

                13.1.5.3. Financial Overview

                13.1.5.4. Strategic Overview

                13.1.5.5. SWOT Analysis

            13.1.6. Medtronic

                13.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.1.6.2. Product Portfolio

                13.1.6.3. Financial Overview

                13.1.6.4. Strategic Overview

                13.1.6.5. SWOT Analysis

            13.1.7. Nova Biomedical Corporation

                13.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.1.7.2. Product Portfolio

                13.1.7.3. Financial Overview

                13.1.7.4. Strategic Overview

                13.1.7.5. SWOT Analysis

            13.1.8. Senseonics Incorporated

                13.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.1.8.2. Product Portfolio

                13.1.8.3. Strategic Overview

                13.1.8.4. SWOT Analysis

            13.1.9. Livongo

                13.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.1.9.2. Product Portfolio

                13.1.9.3. Strategic Overview

                13.1.9.4. SWOT Analysis

            13.1.10. BeatO

                13.1.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.1.10.2. Product Portfolio

                13.1.10.3. Strategic Overview

                13.1.10.4. SWOT Analysis

            13.1.11. Jana Care

                13.1.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.1.11.2. Product Portfolio

                13.1.11.3. Strategic Overview

                13.1.11.4. SWOT Analysis

            13.1.12. iXensor

                13.1.12.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.1.12.2. Product Portfolio

                13.1.12.3. Strategic Overview

                13.1.12.4. SWOT Analysis

            13.1.13. DiaMonTech AG

                13.1.13.1. Company Overview (HQ, Business Segments, Employee Strength)

                13.1.13.2. Product Portfolio

                13.1.13.3. Financial Overview

                13.1.13.4. Strategic Overview

                13.1.13.5. SWOT Analysis

    List of Tables

    Table 01: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017‒2028

    Table 02: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Guardian Real Time CGM System, 2017‒2028

    Table 03: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by FreeStyle Navigator, 2017‒2028

    Table 04: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom Seven Plus CGM System, 2017‒2028

    Table 05: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom G4 Platinum, 2017‒2028

    Table 06: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by MiniMed Paradigm Revel/Veo Systems, 2017‒2028

    Table 07: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Others, 2017–2028

    Table 08: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by End-user, 2017–2028

    Table 09: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Region, 2017–2028

    Table 10: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Country, 2017–2028

    Table 11: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017‒2028

    Table 12: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Guardian Real Time CGM System, 2017‒2028

    Table 13: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by FreeStyle Navigator, 2017‒2028

    Table 14: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom Seven Plus CGM System, 2017‒2028

    Table 15: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom G4 Platinum, 2017–2028

    Table 16: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by MiniMed Paradigm Revel/Veo Systems, 2017–2028

    Table 17: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Others, 2017–2028

    Table 18: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2028

    Table 19: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017‒2028

    Table 20: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Guardian Real Time CGM System, 2017‒2028

    Table 21: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by FreeStyle Navigator, 2017‒2028

    Table 22: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom Seven Plus CGM System, 2017‒2028

    Table 23: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom G4 Platinum, 2017–2028

    Table 24: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by MiniMed Paradigm Revel/Veo Systems, 2017–2028

    Table 25: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Others, 2017–2028

    Table 26: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Country, 2017–2028

    Table 27: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017‒2028

    Table 28: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Guardian Real Time CGM System, 2017‒2028

    Table 29: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by FreeStyle Navigator, 2017‒2028

    Table 30: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom Seven Plus CGM System, 2017‒2028

    Table 31: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom G4 Platinum, 2017–2028

    Table 32: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by MiniMed Paradigm Revel/Veo Systems, 2017–2028

    Table 33: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Others, 2017–2028

    Table 34: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Country, 2017–2028

    Table 35: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017‒2028

    Table 36: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Guardian Real Time CGM System, 2017‒2028

    Table 37: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by FreeStyle Navigator, 2017‒2028

    Table 38: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom Seven Plus CGM System, 2017‒2028

    Table 39: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Dexcom G4 Platinum, 2017–2028

    Table 40: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by MiniMed Paradigm Revel/Veo Systems, 2017–2028

    Table 41: Latin America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Others, 2017–2028

    Table 42: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Country, 2017–2028

    Table 43: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Device/Brand, 2017‒2028

    Table 44: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by Guardian Real Time CGM System, 2017‒2028

    Table 45: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, by FreeStyle Navigator, 2017‒2028

    List of Figures

    Figure 01: Global Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, 2017–2028

    Figure 02: Global Continuous Glucose Monitoring Market Value Share, by Device/Brand, 2020

    Figure 03: Global Continuous Glucose Monitoring Market Value Share Analysis, by Device/Brand, 2020 and 2028

    Figure 04: Global Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand, 2021–2028

    Figure 05: Global Continuous Glucose Monitoring Market Value (US$ Mn), by Guardian Real Time CGM System, 2017‒2028

    Figure 06: Global Continuous Glucose Monitoring Market Value (US$ Mn), by FreeStyle Navigator, 2017‒2028

    Figure 07: Global Continuous Glucose Monitoring Market Value (US$ Mn), by Dexcom Seven Plus CGM System, 2017‒2028

    Figure 08: Global Continuous Glucose Monitoring Market Value (US$ Mn), by Dexcom G4 Platinum, 2017‒2028

    Figure 09: Global Continuous Glucose Monitoring Market Value (US$ Mn), by MiniMed Paradigm Revel/Veo Systems, 2017‒2028

    Figure 10: Global Continuous Glucose Monitoring Market Value (US$ Mn), by Others, 2017‒2028

    Figure 11: Global Continuous Glucose Monitoring Market Value Share Analysis, by Region, 2020 and 2028

    Figure 12: Global Continuous Glucose Monitoring Market Attractiveness Analysis, by Region, 2021–2028

    Figure 13: North America Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, 2017–2028

    Figure 14: North America Continuous Glucose Monitoring Market Value Share Analysis, by Country, 2020 and 2028

    Figure 15: North America Continuous Glucose Monitoring Market Attractiveness Analysis, by Country, 2021–2028

    Figure 16: North America Continuous Glucose Monitoring Market Value Share Analysis, by Device/Brand, 2020 and 2028

    Figure 17: North America Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand, 2021–2028

    Figure 18: Europe Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, 2017–2028

    Figure 19: Europe Continuous Glucose Monitoring Market Value Share Analysis, by Country/Sub–region, 2020 and 2028

    Figure 20: Europe Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/Sub–region, 2021–2028

    Figure 21: Europe Continuous Glucose Monitoring Market Value Share Analysis, by Device/Brand, 2020 and 2028

    Figure 22: Europe Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand, 2021–2028

    Figure 23: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Mn) Forecast, 2017–2028

    Figure 24: Asia Pacific Continuous Glucose Monitoring Market Value Share Analysis, by Country/Sub-region, 2020 and 2028

    Figure 25: Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/ Sub-region, 2021–2028

    Figure 26: Asia Pacific Continuous Glucose Monitoring Market Value Share Analysis, by Device/Brand, 2020 and 2028

    Figure 27: Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand, 2021–2028

    Figure 28: Latin America Continuous Glucose Monitoring Market Value Share Analysis, by Country/Sub-region, 2020 and 2028

    Figure 29: Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/ Sub-region, 2021–2028

    Figure 30: Latin America Continuous Glucose Monitoring Market Value Share Analysis, by Device/Brand, 2020 and 2028

    Figure 31: Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand, 2021–2028

    Figure 32: Middle East & Africa Continuous Glucose Monitoring Market Value Share Analysis, by Country/Sub-region, 2020 and 2028

    Figure 33: Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/ Sub-region, 2021–2028

    Figure 34: Middle East & Africa Continuous Glucose Monitoring Market Value Share Analysis, by Device/Brand, 2020 and 2028

    Figure 35: Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, by Device/Brand, 2021–2028

    Figure 36: North America - Company Share Analysis, 2020

    Figure 37: Europe - Company Share Analysis, 2020

    Figure 38: Asia Pacific - Company Share Analysis, 2020

    Figure 39: Latin America - Company Share Analysis, 2020

    Figure 40: Middle East & Africa - Company Share Analysis, 2020

Google translate

Copyright © Transparency Market Research, Inc. All Rights reserved